HFrEF patients see quality of life gains with yoga-based cardiac rehab

15 hours ago
Jairia Dela Cruz
Jairia Dela CruzSenior Medical Writer; MIMS
Jairia Dela Cruz
Jairia Dela Cruz Senior Medical Writer; MIMS
HFrEF patients see quality of life gains with yoga-based cardiac rehab

A cardiac rehabilitation programme based on yoga improves the quality of life (QoL) of patients with heart failure with reduced ejection fraction (HFrEF) but does not appear to have any significant effect on the incidence of major adverse cardiovascular events (MACE), as shown in the Yoga-CaRe HF trial.

At 3 months, there was a mean difference of –8.1 in Minnesota Living with Heart Failure Questionnaire (MLHFQ) scores between the group of patients who underwent yoga-based cardiac rehab and the group of those who received enhanced standard of care, favouring the yoga group (p<0.001), reported Prof Dorairaj Prabhakaran from the Centre for Chronic Disease Control, New Delhi, India. [AHA 2026, abstract 21982]

The difference in QoL gains as measured by the MLHFQ scores between the two groups persisted across the trial: at the 6-month (–8.4), 12-month (–9.2), and 24-month (–7.2) time points, Prabhakaran added.

The co-primary outcome—the composite of all-cause mortality, all-cause hospitalization, and stroke during a median follow-up of 15 months—was similar between the two groups, occurring in 21 percent of patients in the yoga group vs 22.8 percent in the enhanced care group (adjusted hazard ratio [aHR], 0.90, 95 percent confidence interval [CI], 0.70–1.05; p=0.18).

These findings were consistent across all prespecified subgroups, Prabhakaran noted.

However, per-protocol analyses showed a clinical benefit among the most adherent patients in the yoga group, he added. The risk of MACE was lower by 27 percent to 28 percent among patients who practiced yoga at home for more than 5 days a week (aHR, 0.72, 95 percent CI, 0.56–0.91) and those who trained with yoga for more than 255 min per week (aHR, 0.73, 95 percent CI, 0.57–0.92) compared with those in the enhanced care group.

Results for other outcomes at 3 months favoured yoga vs enhanced care, with significant differences observed in the 6-min walk distance (mean difference, 25.5 m; p<0.001), quality-adjusted value (mean difference, 0.05 points; p<0.001), tobacco cessation (risk ratio, 1.28, 95 percent CI, 1.09–1.50), and frailty (risk ratio, 0.73, 95 percent CI, 0.67–0.78).

Moreover, caregiver’s health at 3 months was significantly better in the yoga group vs the enhanced care group, as reflected by significant differences in QoL EQ-5D-5L score (mean difference, 0.70), quality-adjusted utility-values (mean difference, 0.009), and depression PHQ-9 score (mean difference, –0.60).

“The yoga-based cardiac rehabilitation was safe. There were no adverse events, particularly injuries, that were reported during the trial,” Prabhakaran said.

Keeping patients engaged

“From an outcomes perspective, the most conservative interpretation is Yoga-CaRe is a neutral trial,” according to study discussant Prof Justin Ezekowitz from the University of Alberta, Canada.

Nevertheless, the improvements in QoL and functional outcomes make yoga a valid cardiac rehabilitation intervention, Ezekowitz added.

Ezekowitz urged clinicians to prioritize cardiac rehabilitation referrals for HF patients, emphasizing the need to offer options tailored to patient preferences.

“We need to offer more options—yoga, Tai Chi, high-intensity interval training, or whatever it takes to get patients engaged in cardiac rehabilitation,” he said, “[because] adherence matters in every activity that is exercise-based.”

“Perhaps things like yoga breathing and posture may not have been on everybody’s radar today in terms of what intervention you’re thinking next for your patients, but it probably should be,” Ezekowitz concluded.

Yoga-CaRe HF

Conducted at 16 tertiary care hospitals in India, the trial included 3,492 adult patients with HFrEF, with New York Heart Association (NYHA) class II or III symptoms, who were recruited in hospital and outpatient settings.

The patients were randomly assigned to undergo yoga-based cardiac rehab (n=1,737; mean age 56.8 years, 27 percent female) or enhanced standard care (n=1,755; mean age 57.2 years, 26.9 percent female). All patients received guideline-directed medical therapy (GDMT).

The yoga group received a health education booklet, guided behaviour change, and goal-setting assistance, plus 20 supervised yoga sessions over 3 months. The sessions included a combination of in-person, virtual, and at-home instruction from a board-certified yoga and naturopathy practitioner. After 3 months, patients received one additional session every 3 months through the 24 months of follow-up. Patients were expected to practice yoga at home daily.

The enhanced care group received the same written educational booklet on living well with HF plus three health education/information sessions over 3 months, with no supervised exercise.

At baseline, around half of the patients were in NYHA functional class III, and 65 percent had an ischaemic HF aetiology. Medications included beta-blockers (84 percent), renin-angiotensin-aldosterone system inhibitors (77 percent), mineralocorticoid receptor antagonists (70 percent), and SGLT-2 inhibitors (60 percent). Patients were on quadruple GDMT in 38 percent, and triple GDMT in approximately 50 percent.